Published in J Biomed Opt on February 01, 2011
Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology (2010) 1.48
Detection of intestinal dysplasia using angle-resolved low coherence interferometry. J Biomed Opt (2011) 1.06
Sapphire ball lens-based fiber probe for common-path optical coherence tomography and its applications in corneal and retinal imaging. Opt Lett (2012) 0.96
Fiber-optic interferometric two-dimensional scattering-measurement system. Opt Lett (2010) 0.90
Wavelet transform fast inverse light scattering analysis for size determination of spherical scatterers. Biomed Opt Express (2014) 0.86
A scattering phantom for observing long range order with two-dimensional angle-resolved Low-Coherence Interferometry. Biomed Opt Express (2013) 0.86
Noise characterization of supercontinuum sources for low-coherence interferometry applications. J Opt Soc Am A Opt Image Sci Vis (2014) 0.82
Evaluation of hybrid algorithm for analysis of scattered light using ex vivo nuclear morphology measurements of cervical epithelium. Biomed Opt Express (2015) 0.82
Angle-resolved low-coherence interferometry: an optical biopsy technique for clinical detection of dysplasia in Barrett's esophagus. Expert Rev Gastroenterol Hepatol (2012) 0.81
Angle-resolved low coherence interferometry for detection of dysplasia in Barrett's esophagus. Gastroenterology (2011) 0.81
Co-localized confocal Raman spectroscopy and optical coherence tomography (CRS-OCT) for depth-resolved analyte detection in tissue. Biomed Opt Express (2015) 0.80
Advances in optical adjunctive AIDS for visualisation and detection of oral malignant and potentially malignant lesions. Int J Dent (2013) 0.79
Nuclear morphology measurements with angle-resolved low coherence interferometry for application to cell biology and early cancer detection. Anal Cell Pathol (Amst) (2011) 0.77
Development of angle-resolved low coherence interferometry for clinical detection of dysplasia. J Carcinog (2011) 0.77
Sapphire ball lensed fiber probe for common-path optical coherence tomography in ocular imaging and sensing. Proc SPIE Int Soc Opt Eng (2013) 0.75
Feasibility of clinical detection of cervical dysplasia using angle-resolved low coherence interferometry measurements of depth-resolved nuclear morphology. Int J Cancer (2016) 0.75
Ultrahigh-resolution, high-speed, Fourier domain optical coherence tomography and methods for dispersion compensation. Opt Express (2004) 6.60
Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt (2004) 5.16
Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol (2002) 3.94
A fluorescence confocal endomicroscope for in vivo microscopy of the upper- and the lower-GI tract. Gastrointest Endosc (2005) 3.79
Detection of preinvasive cancer cells. Nature (2000) 3.20
The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest Endosc (2006) 2.71
Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology (2001) 2.46
Cellular organization and substructure measured using angle-resolved low-coherence interferometry. Biophys J (2002) 2.40
Fiber optic probes for biomedical optical spectroscopy. J Biomed Opt (2003) 2.29
Comprehensive esophageal microscopy by using optical frequency-domain imaging (with video). Gastrointest Endosc (2007) 2.26
Barrett's oesophagus. Lancet (2009) 2.21
Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut (2008) 2.20
Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy. Gastroenterology (2000) 2.08
Ultrahigh resolution optical coherence tomography of Barrett's esophagus: preliminary descriptive clinical study correlating images with histology. Endoscopy (2007) 2.00
Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus. Gut (2006) 1.78
In vivo histopathology for detection of gastrointestinal neoplasia with a portable, confocal miniprobe: an examiner blinded analysis. Clin Gastroenterol Hepatol (2007) 1.74
High-resolution miniprobe-based confocal microscopy in combination with video mosaicing (with video). Gastrointest Endosc (2007) 1.74
Light scattering measurements of subcellular structure provide noninvasive early detection of chemotherapy-induced apoptosis. Cancer Res (2009) 1.51
In situ detection of nuclear atypia in Barrett's esophagus by using angle-resolved low-coherence interferometry. Gastrointest Endosc (2007) 1.34
Fiber-optic-bundle-based optical coherence tomography. Opt Lett (2005) 1.33
Elastic scattering spectroscopy for the diagnosis of colonic lesions: initial results of a novel optical biopsy technique. Gastrointest Endosc (2006) 1.31
Fourier-domain angle-resolved low coherence interferometry through an endoscopic fiber bundle for light-scattering spectroscopy. Opt Lett (2006) 1.30
In vivo three-dimensional spectral domain endoscopic optical coherence tomography using a microelectromechanical system mirror. Opt Lett (2007) 1.28
Detection and treatment of dysplasia in Barrett's esophagus: a pivotal challenge in translating biophotonics from bench to bedside. J Biomed Opt (2007) 1.16
In vivo near-infrared Raman spectroscopy: demonstration of feasibility during clinical gastrointestinal endoscopy. Photochem Photobiol (2000) 1.16
Fluorescence endoscopy of gastrointestinal diseases: basic principles, techniques, and clinical experience. Endoscopy (1998) 1.13
Ultrahigh resolution optical biopsy with endoscopic optical coherence tomography. Opt Express (2004) 1.08
Optical modeling of an ultrathin scanning fiber endoscope, a preliminary study of confocal versus non-confocal detection. Opt Express (2005) 1.04
Numerical dispersion compensation for Partial Coherence Interferometry and Optical Coherence Tomography. Opt Express (2001) 1.02
Re-evaluation of model-based light-scattering spectroscopy for tissue spectroscopy. J Biomed Opt (2009) 0.98
Barrett's oesophagus: new diagnostic and therapeutic techniques. Scand J Gastroenterol Suppl (2002) 0.88
Future expectations in digestive endoscopy: competition with other novel imaging techniques. Best Pract Res Clin Gastroenterol (2008) 0.78
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15
Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med (2011) 6.79
American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93
Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17
Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc (2010) 3.74
A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology (2004) 3.50
Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc (2008) 3.13
Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol (2007) 2.94
American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology (2008) 2.79
Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis. Am J Gastroenterol (2012) 2.70
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2009) 2.53
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol (2011) 2.47
Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol (2009) 2.46
Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 2.28
RNA expression analysis of formalin-fixed paraffin-embedded tumors. Lab Invest (2007) 2.25
American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology (2008) 2.23
Digestive and liver diseases statistics, 2004. Gastroenterology (2004) 2.14
Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res (2008) 2.13
Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med (2009) 2.11
Quality indicators for colonoscopy. Am J Gastroenterol (2014) 2.06
Liver-vessel cancellation artifact on in-phase and out-of-phase MRI imaging: a sign of ultra-high liver fat content. J Magn Reson Imaging (2011) 1.98
Photothermal optical coherence tomography of epidermal growth factor receptor in live cells using immunotargeted gold nanospheres. Nano Lett (2008) 1.98
A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology (2009) 1.95
Molecular imaging true-colour spectroscopic optical coherence tomography. Nat Photonics (2011) 1.86
Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study. Gastrointest Endosc (2011) 1.82
Dual window method for processing spectroscopic optical coherence tomography signals with simultaneously high spectral and temporal resolution. Opt Express (2009) 1.81
Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc (2010) 1.79
Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol (2013) 1.75
Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Am J Gastroenterol (2003) 1.73
Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia. Dig Dis Sci (2009) 1.70
Single and multiple dose pharmacokinetics of maraviroc in saliva, semen, and rectal tissue of healthy HIV-negative men. J Infect Dis (2011) 1.70
Dual-interference-channel quantitative-phase microscopy of live cell dynamics. Opt Lett (2009) 1.67
Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. Gastrointest Endosc (2012) 1.67
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67
Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital. J Clin Gastroenterol (2011) 1.66
Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology (2012) 1.65
A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res (2009) 1.65
The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol (2012) 1.64
Tissue self-affinity and polarized light scattering in the born approximation: a new model for precancer detection. Phys Rev Lett (2006) 1.58
Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2005) 1.52
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52
Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium. Gut (2013) 1.52
Light scattering measurements of subcellular structure provide noninvasive early detection of chemotherapy-induced apoptosis. Cancer Res (2009) 1.51
The impact of the changing health care environment on the health and well-being of faculty at four medical schools. Acad Med (2006) 1.50
A 25-year analysis of the American College of Gastroenterology research grant program: factors associated with publication and advancement in academics. Am J Gastroenterol (2009) 1.49
Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc (2011) 1.49
Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology (2010) 1.48
Barrett's esophagus and the costs of "doing something". Gastrointest Endosc (2007) 1.47
Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). Gastrointest Endosc (2012) 1.46
In situ assessment of intraepithelial neoplasia in hamster trachea epithelium using angle-resolved low-coherence interferometry. Cancer Epidemiol Biomarkers Prev (2007) 1.45
Assessing hemoglobin concentration using spectroscopic optical coherence tomography for feasibility of tissue diagnostics. Biomed Opt Express (2010) 1.45
Single nucleotide polymorphisms of caudal type homeobox 1 and 2 are associated with Barrett's esophagus. Dig Dis Sci (2013) 1.42
Determining nuclear morphology using an improved angle-resolved low coherence interferometry system. Opt Express (2003) 1.41
Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival? J Clin Oncol (2005) 1.40
A cross-sectional analysis of the prevalence of Barrett esophagus in otolaryngology patients with laryngeal symptoms. J Clin Gastroenterol (2013) 1.40
Preventive therapy in perforated colonic diverticular disease? Calcium channel blockers may hold the key. Gastroenterology (2004) 1.39
Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol (2008) 1.38
Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol (2010) 1.37
Nuclear morphology measurements using Fourier domain low coherence interferometry. Opt Express (2005) 1.35
In situ detection of nuclear atypia in Barrett's esophagus by using angle-resolved low-coherence interferometry. Gastrointest Endosc (2007) 1.34
Label-free plasmonic detection of biomolecular binding by a single gold nanorod. Anal Chem (2008) 1.34
Toward uniformity in the diagnosis of eosinophilic esophagitis (EoE): the effect of guidelines on variability of diagnostic criteria for EoE. Am J Gastroenterol (2011) 1.34
The use of carbon dioxide for insufflation during GI endoscopy: a systematic review. Gastrointest Endosc (2009) 1.32
Temporal coherence and time-frequency distributions in spectroscopic optical coherence tomography. J Opt Soc Am A Opt Image Sci Vis (2007) 1.30
Fourier-domain angle-resolved low coherence interferometry through an endoscopic fiber bundle for light-scattering spectroscopy. Opt Lett (2006) 1.30
Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology (2011) 1.29
Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance. Am J Physiol Gastrointest Liver Physiol (2007) 1.29
Measuring morphological features using light-scattering spectroscopy and Fourier-domain low-coherence interferometry. Opt Lett (2010) 1.28
Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology (2012) 1.28
Randomized comparison of virtual microscopy and traditional glass microscopy in diagnostic accuracy among dermatology and pathology residents. Hum Pathol (2009) 1.27
Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst (2013) 1.25
Two-step-only phase-shifting interferometry with optimized detector bandwidth for microscopy of live cells. Opt Express (2009) 1.24
Scanning fiber angle-resolved low coherence interferometry. Opt Lett (2009) 1.23
Quantitative microscopy and nanoscopy of sickle red blood cells performed by wide field digital interferometry. J Biomed Opt (2011) 1.23
Molecular imaging of epidermal growth factor receptor in live cells with refractive index sensitivity using dark-field microspectroscopy and immunotargeted nanoparticles. J Biomed Opt (2008) 1.23
Experimental verification of T-matrix-based inverse light scattering analysis for assessing structure of spheroids as models of cell nuclei. Appl Opt (2009) 1.22
Impact of the 2008-2009 economic recession on screening colonoscopy utilization among the insured. Clin Gastroenterol Hepatol (2011) 1.21
Quantitative phase microscopy of articular chondrocyte dynamics by wide-field digital interferometry. J Biomed Opt (2010) 1.21
Impact of comorbidity on colorectal cancer screening in the veterans healthcare system. Clin Gastroenterol Hepatol (2007) 1.21
Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas. Gastroenterology (2002) 1.20
Rational selection of gold nanorod geometry for label-free plasmonic biosensors. ACS Nano (2009) 1.19
Epidemiology and management of oesophageal coin impaction in children. Dig Liver Dis (2012) 1.18
Quality indicators common to all GI endoscopic procedures. Gastrointest Endosc (2014) 1.17
Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus. Clin Gastroenterol Hepatol (2012) 1.15